Logo image of MCS

MARCUS CORPORATION (MCS) Stock Fundamental Analysis

USA - NYSE:MCS - US5663301068 - Common Stock

15.9 USD
-0.09 (-0.56%)
Last: 9/17/2025, 8:04:00 PM
15.9 USD
0 (0%)
After Hours: 9/17/2025, 8:04:00 PM
Fundamental Rating

4

Overall MCS gets a fundamental rating of 4 out of 10. We evaluated MCS against 80 industry peers in the Entertainment industry. There are concerns on the financial health of MCS while its profitability can be described as average. MCS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MCS had positive earnings in the past year.
MCS had a positive operating cash flow in the past year.
In the past 5 years MCS reported 4 times negative net income.
MCS had a positive operating cash flow in 4 of the past 5 years.
MCS Yearly Net Income VS EBIT VS OCF VS FCFMCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

The Return On Assets of MCS (1.46%) is better than 63.75% of its industry peers.
MCS has a better Return On Equity (3.30%) than 66.25% of its industry peers.
MCS's Return On Invested Capital of 2.26% is fine compared to the rest of the industry. MCS outperforms 63.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MCS is significantly below the industry average of 9.25%.
The 3 year average ROIC (1.74%) for MCS is below the current ROIC(2.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.46%
ROE 3.3%
ROIC 2.26%
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
MCS Yearly ROA, ROE, ROICMCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

MCS has a better Profit Margin (1.91%) than 62.50% of its industry peers.
The Operating Margin of MCS (3.66%) is better than 65.00% of its industry peers.
In the last couple of years the Operating Margin of MCS has declined.
With a Gross Margin value of 38.85%, MCS perfoms like the industry average, outperforming 46.25% of the companies in the same industry.
In the last couple of years the Gross Margin of MCS has remained more or less at the same level.
Industry RankSector Rank
OM 3.66%
PM (TTM) 1.91%
GM 38.85%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
MCS Yearly Profit, Operating, Gross MarginsMCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MCS is destroying value.
MCS has less shares outstanding than it did 1 year ago.
MCS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MCS has an improved debt to assets ratio.
MCS Yearly Shares OutstandingMCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MCS Yearly Total Debt VS Total AssetsMCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.62, we must say that MCS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MCS (1.62) is comparable to the rest of the industry.
MCS has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
MCS has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.62
ROIC/WACC0.31
WACC7.35%
MCS Yearly LT Debt VS Equity VS FCFMCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MCS has a Current Ratio of 0.39. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.39, MCS is doing worse than 83.75% of the companies in the same industry.
MCS has a Quick Ratio of 0.39. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.39, MCS is doing worse than 82.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
MCS Yearly Current Assets VS Current LiabilitesMCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

MCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 159.21%, which is quite impressive.
MCS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.27%.
Measured over the past years, MCS shows a decrease in Revenue. The Revenue has been decreasing by -2.17% on average per year.
EPS 1Y (TTM)159.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%135.94%
Revenue 1Y (TTM)13.27%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%17.05%

3.2 Future

Based on estimates for the next years, MCS will show a very strong growth in Earnings Per Share. The EPS will grow by 69.10% on average per year.
Based on estimates for the next years, MCS will show a small growth in Revenue. The Revenue will grow by 3.94% on average per year.
EPS Next Y245.02%
EPS Next 2Y111.81%
EPS Next 3Y69.1%
EPS Next 5YN/A
Revenue Next Year6.5%
Revenue Next 2Y5.33%
Revenue Next 3Y3.94%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MCS Yearly Revenue VS EstimatesMCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MCS Yearly EPS VS EstimatesMCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.33, which means the current valuation is very expensive for MCS.
MCS's Price/Earnings ratio is a bit cheaper when compared to the industry. MCS is cheaper than 77.50% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. MCS is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 24.60 indicates a rather expensive valuation of MCS.
MCS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MCS is cheaper than 76.25% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MCS to the average of the S&P500 Index (22.70), we can say MCS is valued inline with the index average.
Industry RankSector Rank
PE 35.33
Fwd PE 24.6
MCS Price Earnings VS Forward Price EarningsMCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MCS indicates a rather cheap valuation: MCS is cheaper than 86.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.84
MCS Per share dataMCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MCS's earnings are expected to grow with 69.10% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y111.81%
EPS Next 3Y69.1%

4

5. Dividend

5.1 Amount

MCS has a Yearly Dividend Yield of 1.99%.
MCS's Dividend Yield is rather good when compared to the industry average which is at 12.26. MCS pays more dividend than 91.25% of the companies in the same industry.
MCS's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

The dividend of MCS decreases each year by -13.79%.
MCS has been paying a dividend for at least 10 years, so it has a reliable track record.
MCS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-13.79%
Div Incr Years2
Div Non Decr Years2
MCS Yearly Dividends per shareMCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

58.72% of the earnings are spent on dividend by MCS. This is a bit on the high side, but may be sustainable.
DP58.72%
EPS Next 2Y111.81%
EPS Next 3Y69.1%
MCS Yearly Income VS Free CF VS DividendMCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
MCS Dividend Payout.MCS Dividend Payout, showing the Payout Ratio.MCS Dividend Payout.PayoutRetained Earnings

MARCUS CORPORATION

NYSE:MCS (9/17/2025, 8:04:00 PM)

After market: 15.9 0 (0%)

15.9

-0.09 (-0.56%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners79.4%
Inst Owner Change-0.54%
Ins Owners5.01%
Ins Owner Change0.78%
Market Cap497.83M
Analysts84.44
Price Target25.5 (60.38%)
Short Float %3.18%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly Dividend0.28
Dividend Growth(5Y)-13.79%
DP58.72%
Div Incr Years2
Div Non Decr Years2
Ex-Date08-25 2025-08-25 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.53%
Min EPS beat(2)-10.24%
Max EPS beat(2)15.3%
EPS beat(4)2
Avg EPS beat(4)-2.7%
Min EPS beat(4)-73%
Max EPS beat(4)57.12%
EPS beat(8)3
Avg EPS beat(8)-322.91%
EPS beat(12)5
Avg EPS beat(12)-221.55%
EPS beat(16)8
Avg EPS beat(16)-136.28%
Revenue beat(2)2
Avg Revenue beat(2)3.53%
Min Revenue beat(2)1.76%
Max Revenue beat(2)5.29%
Revenue beat(4)4
Avg Revenue beat(4)4.38%
Min Revenue beat(4)1.76%
Max Revenue beat(4)8.6%
Revenue beat(8)7
Avg Revenue beat(8)3.4%
Revenue beat(12)11
Avg Revenue beat(12)3.65%
Revenue beat(16)15
Avg Revenue beat(16)6.74%
PT rev (1m)0%
PT rev (3m)-0.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.63%
EPS NY rev (1m)-16.42%
EPS NY rev (3m)-22.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.1%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.33%
Valuation
Industry RankSector Rank
PE 35.33
Fwd PE 24.6
P/S 0.64
P/FCF N/A
P/OCF 6.27
P/B 1.11
P/tB 1.33
EV/EBITDA 6.84
EPS(TTM)0.45
EY2.83%
EPS(NY)0.65
Fwd EY4.07%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)2.54
OCFY15.94%
SpS24.78
BVpS14.32
TBVpS11.93
PEG (NY)0.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.3%
ROCE 3.3%
ROIC 2.26%
ROICexc 2.3%
ROICexgc 2.52%
OM 3.66%
PM (TTM) 1.91%
GM 38.85%
FCFM N/A
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
ROICexc(3y)1.83%
ROICexc(5y)N/A
ROICexgc(3y)2.03%
ROICexgc(5y)N/A
ROCE(3y)2.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-14.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-14.65%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 1.81
Cap/Depr 118.61%
Cap/Sales 10.81%
Interest Coverage 3.38
Cash Conversion 80.12%
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z 1.62
F-Score7
WACC7.35%
ROIC/WACC0.31
Cap/Depr(3y)76.34%
Cap/Depr(5y)56.25%
Cap/Sales(3y)7.17%
Cap/Sales(5y)6.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)159.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%135.94%
EPS Next Y245.02%
EPS Next 2Y111.81%
EPS Next 3Y69.1%
EPS Next 5YN/A
Revenue 1Y (TTM)13.27%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%17.05%
Revenue Next Year6.5%
Revenue Next 2Y5.33%
Revenue Next 3Y3.94%
Revenue Next 5YN/A
EBIT growth 1Y209.42%
EBIT growth 3YN/A
EBIT growth 5Y-20.28%
EBIT Next Year315.84%
EBIT Next 3Y69.89%
EBIT Next 5YN/A
FCF growth 1Y-109.14%
FCF growth 3Y-5.39%
FCF growth 5Y-20.4%
OCF growth 1Y-6.95%
OCF growth 3Y30.94%
OCF growth 5Y-5.98%